General considerations on rapid desensitization for drug hypersensitivity - A consensus statement

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 11, 2010, Pages 1357-1366

  Cernadas, J R ^a   Brockow, K ^b   Romano, A ^c   Aberer, W ^d   Torres, M J ^e   Bircher, A ^f   Campi, P ^g   Sanz, M L ^h   Castells, M ⁱ   Demoly, P ^j   Pichler, W J ^k  

^a Medical University   (Portugal)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g Allergy Clinic   (Italy)

^h UNIVERSITY CLINIC OF NAVARRA   (Spain)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j HÔPITAL ARNAUD DE VILLENEUVE   (France)

^k UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

Desensitization; Drug hypersensitivity; Graded challenge; Tolerance induction

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN E; INSULIN; MONOCLONAL ANTIBODY; PENICILLIN G; SULFONAMIDE;

ADVERSE DRUG REACTION; ANAPHYLAXIS; CHEMOTHERAPY; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG SPECIFICITY; HUMAN; HYPERSENSITIVITY REACTION; PREMEDICATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS;

EID: 78649241782     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02441.x     Document Type: Review

References (99)

1. Demoly P, Bousquet J,. Epidemiology of drug allergy. Curr Opinion Allergy Clin Immunol 2001; 1: 305-310.
2. Lazarou J, Pomeranz BH, Corey PN,. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
3. Gomes ER, Demoly P,. Epidemiology of hypersensitivity drug reactions. Curr Opinion Allergy Clin Immunol 2005; 5: 309-316.
4. Johansson SGO, Hourihane JO'B, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. Position paper. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-824.
5. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma, and Immunology and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999; 83 (6 pt 3): 665-700.
6. Drain KL, Volcheck GW,. Preventing and managing drug-induced anaphylaxis. Drug Saf 2001; 24: 843-853.
7. Van Der Klauw M, Wilson J, Stricker B,. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands 1974-1994 and review of the literature. Clin Exp Allergy 1996; 26: 1355-1363.
8. Torres MJ, Mayorca C, Blanca M,. Drug Hypersensitivity. In:, Pichler W, editor. Urticaria and anaphylaxis due to Betalactams (Penicillins and Cephalosporins). Bern: Karger Verlag, 2007: 190-203.
9. Neukomm C, Yawalkar N, Helbling A, Pichler WJ,. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Invest Allergy Clin Immunol 2001; 11: 275-284.
10. Mockenhaupt M,. Dermatology and Venerology. In:, Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, Braun-Falco's âš, editors. Severe cutaneous adverse reactions. Heidelberg: Springer Medizin Verlag, 2008: 473-484.
11. Allanore L, Roujeau J-C,. Drug Hypersensitivity. In:, Pichler W, editor. Clinic and pathogenesis of Severe Bullous Skin Reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis. Bern: Karger Verlag, 2007: 267-277.
12. Straumann A, Bauer M, Pichler WJ, Pirovino M,. Acute pancreatitis due to pyritynol. Gastroenterology 1998; 115: 452-454.
13. Maria VA, Victorino RM,. Diagnostic value of specific T-cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 1997; 41: 534-540.
14. Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK,. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 2000; 23: 483-507.
15. Pichler WJ, Yawalkar N, Britschgi M, Depta J, Strasser I, Schmid S, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3: 229-238.
16. Pichler WJ, Yawalkar N, Schmid S, Helbling A,. Pathogenesis of drug induced exanthems. Allergy 2002; 57: 884-893.
17. Britschgi M, Steiner U, Schmid S, Depta JP, Senti G, Bircher A, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 11: 1433-1441.
18. Adkinson NF Jr,. Allergy, Principles and Practice. In:, Middleton E Jr, Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons ER, editors. Drug allergy. New York: Mosby Co, 2003: 1679-1694
19. Bousquet J, Bieber T, Fokkens W, Humbert M, Kowalski ML, Niggemann B, et al. Consensus statements, evidence-based medicine and guidelines in allergic diseases. Allergy 2008; 63: 1-4.
20. Castells M,. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006; 6: 476-481.
21. Solensky R,. Drug hypersensitivity. Med Clin North Am 2006; 90: 233-260.
22. Solensky R,. Drug desensitization. Immunol Allergy Clin North Am 2004; 24: 425-443.
23. Turvey SE, Cronin B, Arnold AD, Dioun AF,. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 2004; 92: 426-432.
24. Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 1999; 17: 1141-1145.
25. Zanotti KM, Rybicki LA, Kennedy AW, Belinson JL, Webster KD, Kulp B, et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 2001; 19: 3126-3129.
26. Berges-Gimeno MP, Stevenson DD,. Nonsteroidal anti-inflammatory drug induced reactions and desensitization. J Asthma 2004; 41: 375-384.
27. Berges-Gimeno MP, Simon RA, Stevenson DD,. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111: 180-186.
28. Berges-Gimeno MP, Simon RA, Stevenson DD,. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003; 90: 338-341.
29. Feldweg AM, Lee CW, Matulonis UA, Castells M,. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol 2005; 96: 824-829.
30. Sobotka A, Dembo M, Goldstein B, Lichtenstein L,. Antigen specific desensitization of human basophils. J Immunol 1979; 122: 511-517.
31. Shalit M, Levi-Schaffer F,. Challenge of mast cells with increasing amounts of antigen induces desensitization. Clin Exp Allergy 1995; 25: 896-902.
32. Steinman RM, Mellman IS, Muller MA, Cohen ZA,. Endocytosis and recycling of plasma membrane. J Cell Biol 1983; 96: 1-27.
33. Kepley CL,. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005; 138: 29-39.
34. Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, Wright HV, et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 2004; 199: 1491-1502.
35. Malaviya R, Uckum FM,. Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cell. J Immunol 2002; 168: 421-426.
36. Shimoda K, Van DeursenJ, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted STAT6 gene. Nature 1996; 380: 630-633.
37. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, et al. Essential role of STAT6 in IL-4 signaling. Nature 1996; 380: 627-630.
38. Morales AR, Shah N, Castells M,. Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen. Ann Allergy Asthma Immunol 2005; 94: 575-580.
39. Woo HY, Kim YS, Kang NI, Chung WC, Song CH, Choi IW, et al. Mechanism for acute oral desensitization to antibiotics. Allergy 2006; 61: 954-958.
40. Farooque S, Lee T,. Mechanisms of aspirin-sensitive respiratory disease-a two-compartment model. Int Arch Allergy Immunol 2007; 142: 59-63.
41. Castells M,. Drug Hypersensitivity. In:, Pichler W, editor. Drug desensitization in oncology: chemotherapy agents and monoclonal antibodies. Bern: Karger Verlag, 2007: 413-425.
42. Bonfanti P, Pusterla L, Parazzini F, Libanore M, Cgni AE, Franzetti M, et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. Biomed Pharmacother 2000; 54: 56-59.
43. Gorman SK, Zed PJ, Dhingra VK, Ronco JJ,. Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia. Ann Pharmacother 2003; 37: 513-516.
44. Shiohara T, Takahashi R, Kano Y,. Drug Hypersensitivity. In:, Pichler W, editor. Drug-induced hypersensitivity syndromes and viral reactivation. Bern: Karger Verlag, 2007: 251-266.
45. Gruchalla R,. Acute drug desensitization. Clin Exp Allergy 1998; 28: 63-64.
46. Lee CW, Matulonis UA, Castells MC,. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004; 95: 370-376.
47. Boguniewicz M, Leung DY,. Management of patients with allergic reactions to antibiotics. Pediatr Pulmunol 1987; 80: 314-319.
48. Lee CW, Matulonis UA, Castells MC,. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 2005; 99: 393-399.
49. Borish L, Tamir R, Rosenwasser LJ,. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987; 80: 314-319.
50. Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ,. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol 1982; 69: 275-282.
51. Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, Andre P, et al. Six-hour trimethoprim-sulfamethoxazole graded challenge in HIV-infected patients. J Allergy Clin Immunol 1998; 102: 1033-1036.
52. Ghosal S, Taylor CJ,. Intravenous desensitization to ceftazidime in cystic fibrosis patients. J Antimicrob Chemother 1997; 39: 556-557.
53. Earl HS, Sullivan TJ,. Acute desensitization of a patient with cystic fibrosis allergic to both betalactam and aminoglycoside antibiotics. J Allergy Clin Immunol 1987; 79: 477-483.
54. Chopra N, Oppenheimer J, Derimanov GS, Fine PL,. Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Ann Allergy Asthma Immunol 2000; 84: 633-635.
55. Castells M, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122: 574-580.
56. Solensky R,. Drug Hypersensitivity. In:, Pichler W, editor. Desensitization with antibiotics. Bern: Karger Verlag, 2007: 404-412.
57. Stark BJ, Earl HS, Gross GN, Lumry WR, Goodman EL, Sullivan TJ,. Acute and chronic desensitization of penicillin allergic patients using oral penicillin. J Allergy Clin Immunol 1987; 79: 523-532.
58. Herman R, Jick H,. Cutaneous reaction rates to penicillins: oral versus parental. Cutis 1979; 24: 232-234.
59. Sullivan TJ,. Allergy, Principles and Practice. In:, Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, editors. Drug allergy. St. Louis: Mosby Co 1993: 1726-1746.
60. Moyes V, Driver R, Croom A, Mirakian R, Chowdhury TA,. Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion. Diabet Med 2006; 23: 204-206.
61. Radermecker RP, Scheen AJ,. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev 2007; 23: 348-355.
62. Wong JT, Ripple RE, MacLean JA, Marks DR, Bloch KJ,. Vancomycin hypersensitivity: synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol. J Allergy Clin Immunol 1994; 94: 189-194.
63. Sehn LH, Donaldson J, Filewich A, Fitzgerald C, Gill KK, Runzer N, et al. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting. Blood 2007; 109: 4171-4173.
64. Wendel GD Jr, Stark BJ, Jamison RB, Molina RD, Sullivan TJ,. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312: 1229-1232.
65. Madaan A, Li JT,. Cephalosporin allergy. Immunol Allergy Clin North Am 2004; 24: 463-476.
66. Empedrad R, Darter AL, Earl HS, Gruchalla RS,. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003; 112: 629-630.
67. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P,. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
68. Torres MJ, Blanca M, Fernandez J, Romano A, De Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961-972. (Pubitemid 37260337)
69. Burrows JA, Toon M, Bell SC,. Antibiotic desensitization in adults with cystic fibrosis. Respirology 2003; 8: 359-364.
70. Castells M,. Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Curr Opin Allergy Clin Immunol 2006; 6: 271-277.
71. Morgan JS, Adams M, Mason MD,. Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma. Eur J Cancer 1994; 30: 1205-1206.
72. White AA, Stevenson DD, Simon RA,. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005; 95: 330-335.
73. Morgan M, Bowers DC, Gruchalla RS, Khan DA,. Safety and efficacy of repeated monthly carboplatin desensitization. J Allergy Clin Immunol 2004; 114: 974-975.
74. Brown LA, Goldberg ND, Shearer WT,. Long-term ticarcillin desensitization by the continuous oral administration of penicillin. J Allergy Clin Immunol 1982; 69: 51-54.
75. Pfaar O, Klimek L,. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 2006; 6: 161-166.
76. Graybill JR, Sande MA, Reinarz JA, Shapiro RS,. Controlled penicillin anaphylaxis leading to desensitization. South Med J 1974; 67: 62-64.
77. Markman M, Kennedy A, Webster K, Kulp P, Peterson G, Belinson J,. Paclitaxel-associated hypersensitivity reactions: experience of the gynaecologic oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol 2000; 18: 102-105.
78. Ogle SK, Rose MM, Wildes CT,. Development and implementation of a carboplatin desensitization protocol for children with neurofrimomatosis, type I, and hypersensitivity reactions in an outpatient oncology clinic. J Pediatr Oncol Nurs 2002; 19: 122-126.
79. Naclerio R, Mizrahi EA, Adkinson NF Jr,. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983; 71: 294-301.
80. Rodrigues J, Moreira A, Fonseca J, Vaz M,. Oral desensitization to izoniazid. R Port Alergologia 2007; 9: 263-264.
81. Buergin S, Scherer K, Hausermann P, Bircher AJ,. Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance. Int Arch Allergy Immunol 2006; 140: 20-26.
82. Straatmann A, Bahia F, Pedral-Sampaio D, Brites C,. A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides. Braz J Infect Dis 2002; 6: 276-280.
83. Yoshizawa S, Yasuoka A, Kikuchi Y, Honda M, Gatanaga H, Tachikawa N, et al. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol 2000; 85: 241-244.
84. Theodore CM, Holmes D, Rodgers M, McLean KA,. Co-trimoxazole desensitization in HIV-seropositive patients. Int J STD AIDS 1998; 9: 158-161.
85. Palusci VJ, Kaul A, Lawrence RM, Haines KA, Kwittken PL,. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr Infect Dis J 1996; 15: 456-460.
86. Amedeo J, Chichmanian RM, Reboulot B, Vinti H, Rosenthal E, Pesce A, et al. Desensitization in HIV seropositive patients with cotrimoxazole hypersensitivity. A series of 18 cases. Therapie 1994; 49: 463-465.
87. Beall G, Sanwo M, Hussain H,. Drug reactions and desensitization in AIDS. Immunol Allergy Clin North Am 1997; 17: 319-338.
88. Olson JK, Sood AK, Sorosky JI, Anderson B, Buller RE,. Taxol hypersensitivity: rapid retreatment is safe and cost effective. Gynecol Oncol 1998; 68: 25-28.
89. Rose PG, Fusco N, Smrekar M, Mossbruger K, Rodriguez M,. Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity. Gynecol Oncol 2003; 89: 429-433.
90. Somech R, Seaban-Adel K, Atkinson A, Kirby-Allen M,. Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate. Ann Allergy Asthma Immunol 2007; 99: 575-576.
91. AtanaskoviÄ-MarkoviÄ M, NestoroviÄ B,. Desensitization to diphtheria, tetanus and pertussis vaccine. Srp Arh Celok Lek 2003; 131: 427-431.
92. Williams AN, Kabuubi JB, Owen JP, Wells J,. Tetanus immunisation in hypersensitive individuals. J R Army Med Corps 2002; 148: 148-150.
93. Hsu HL, Huang FC, Ni YH, Chang MH,. Steroids used to desensitize penicillamine allergy in Wilson disease. Acta Paediatr Taiwan 1999; 40: 448-450.
94. Parekh K, Burkhart HM, Hatab A, Ross A, Muller BA,. Heparin allergy: successful desensitization for cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130: 1455-1456.
95. Lee JY, Simon RA, Stevenson DD,. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007; 119: 157-164.
96. Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA,. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA 2004; 292: 3017-3023.
97. Hope AP, Woessner KA, Simon RA, Stevenson DD,. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2009; 123: 406-410.
98. Syrigou EI, Karapanagiotou EM, Alamara CV, Boura PG, Saif MW, Syrigos KN,. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol. Clin Colorectal Cancer 2009; 8: 106-109.
99. Jerath MR, Kwan M, Kannarkat M, Mirakhur B, Carey L, Valgus J, et al. A desensitization protocol for the mAb cetuximab. J Allergy Clin Immunol 2009; 123: 260-262.